Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
7,728 results
  • Evaluating single-subject study methods for personal transcriptomic interpretations to advance precision medicine. [Journal Article]
  • BMBMC Med Genomics 2019 Jul 11; 12(Suppl 5):96
  • Rachid Zaim S, Kenost C, … Lussier YA
  • CONCLUSIONS: The "all-against-one" framework provides a honest evaluation framework for single-subject DEG studies since these methods are evaluated, by design, against reference standards produced by unrelated DEG methods. The ss-ensemble method was the only one to reliably produce higher accuracies in all conditions tested in this conservative evaluation framework. However, single-subject methods for identifying DEGs from paired samples need improvement, as no method performed with precision> 90% and obtained moderate levels of recall.
  • Simultaneous optimization of mixed photon energy beams in volumetric modulated arc therapy. [Journal Article]
  • MPMed Phys 2019 Jul 05
  • Momin S, Gräfe J, … Khan R
  • CONCLUSIONS: We demonstrate the first formalism of a large scale simultaneous optimization of mixed photon energy beams for VMAT. Dosimetric comparison of MP - VMAT to single energy VMAT demonstrated potential advantages of using mixed photon energy beams for prostate plans, thus providing an impetus for further testing on a large clinical cohort. This article is protected by copyright. All rights reserved.
  • Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use. [Journal Article]
  • EJEur J Nucl Med Mol Imaging 2019 Jul 01
  • He T, Wang M, … Li Z
  • CONCLUSIONS: We have demonstrated that NTSR1 is a promising molecular marker for prostate cancer based on patient tissue staining. The NTSR targeted probe 18F-DEG-VS-NT demonstrated high tumor to background contrast in animal models, which could be valuable in selecting patients for therapies targeting NTSR1 as well as monitoring therapeutic efficacy during treatment accordingly.
New Search Next